1-3 of 3
Julia J. Scarisbrick
Close
Sort by
Journal Articles

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

Clinical Trials & Observations
Belinda A. Campbell, Gabor Dobos, Zahra Haider, H. Miles Prince, Martine Bagot, Felicity Evison, Carrie van der Weyden, Chris McCormack, Caroline Ram-Wolff, Maryam Miladi, Julia J Scarisbrick
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6639–6647.
https://doi.org/10.1182/bloodadvances.2023011041
Published: 2023
Includes: Supplemental data
Journal Articles

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

Clinical Trials & Observations
Steven M. Horwitz, Julia J. Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E. Akilov, Larisa Geskin, Jose A. Sanches, Pablo L. Ortiz-Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5098–5106.
https://doi.org/10.1182/bloodadvances.2021004710
Published: 2021
Includes: Supplemental data
Journal Articles

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

Clinical Trials & Observations
Duncan Murray, Jack Luke McMurray, Suzy Eldershaw, Hayden Pearce, Nathaniel Davies, Julia J. Scarisbrick, Paul Moss
Journal: Blood Advances
Blood Adv (2019) 3 (4): 519–530.
https://doi.org/10.1182/bloodadvances.2018025114
Published: 2019
Includes: Supplemental data